Krensavage Asset Management, LLC
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 1609251
NEW YORK, NY
Position in VNDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,223,974
-$932,507 QoQ
Shares Held
1,180,388
0.0% QoQ
Ownership
1.95%
of shares outstanding
% of Portfolio
2.74%
of 13F equity value
Holder Rank
#14
of 172 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Krensavage Asset Management, LLC holds $164,705,918 across 9 Biotechnology names. VNDA ranks #6 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ENTA |
Enanta Pharmaceuticals Inc
|
2,866,138 | $41,788,292 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
167,816 | $40,438,621 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
524,786 | $30,028,254 | |
| 4 | EXEL |
Exelixis, Inc.
|
370,693 | $20,169,406 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
390,879 | $13,051,449 | |
| 6 | VNDA |
Vanda Pharmaceuticals Inc.
This page
|
1,180,388 | $7,223,974 | |
| 7 | BNTX |
BioNTech SE
|
59,523 | $5,538,615 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,000 | $3,741,240 |
All Filings in VNDA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,223,974 | 1,180,388 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,156,481 | 1,180,388 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,411,022 | 1,180,388 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $5,890,136 | 1,180,388 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $4,837,447 | 1,024,883 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $3,462,608 | 754,381 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,814,269 | 378,762 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $1,944,867 | 414,684 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $3,741,237 | 662,166 | Shares | Sole | 2024-08-15 | |
| 2023-09-30 | $1,557,053 | 360,429 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $2,391,847 | 362,951 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,454,992 | 361,560 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,551,693 | 345,290 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $3,085,514 | 312,299 | Shares | Sole | 2022-11-15 | |
| 2021-03-31 ALXN | — | 6,912 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 ALXN | — | 364,274 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 ALXN | — | 396,575 | Shares | Sole | 2020-12-08 | |
| 2020-06-30 ALXN | — | 493,170 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 ALXN | — | 462,138 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||